Craft

Establishment Labs

Stock Price

$45.8

2024-08-30

Market Capitalization

$1.3 B

2024-08-30

Revenue

$165.2 M

FY, 2023

Establishment Labs Summary

Company Summary

Overview
Establishment Labs is a medical technology company that provides medical devices for aesthetic and reconstructive plastic surgery. It designs silicone-filled breast and body shaping implants, such as Motiva Flora, a tissue expander with an integrated port that is magnetic resonance imaging (MRI) conditional and is used after breast reconstruction following breast cancer; etc.
Type
Public
Status
Active
Founded
2004
HQ
Alajuela, CR | view all locations
Website
https://establishmentlabs.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Juan José Chacón-Quirós

    Juan José Chacón-Quirós, CEO & Founder and Director

  • Roberto de Mezerville

    Roberto de Mezerville, Chief Technology Officer

  • Raj Denhoy

    Raj Denhoy, Chief Financial Officer

  • Ross Mansbach

    Ross Mansbach, General Counsel & Chief Compliance Officer

Operating MetricsView all

Countries

86
1.2%

FY, 2023

Patents Pending

14
22.2%

FY, 2023

Facility Space, sq. ft.

36K
43.8%

FY, 2023

LocationsView all

1 location detected

  • Alajuela, Provincia de Alajuela HQ

    Costa Rica

    Building B15, Coyol Free Zone, B15

Establishment Labs Financials

Summary Financials

Revenue (Q2, 2024)
$44.1M
Gross profit (Q2, 2024)
$28.9M
Net income (Q2, 2024)
($17.2M)
Cash (Q2, 2024)
$54.6M
EBIT (Q2, 2024)
($9.3M)
Enterprise value
$1.4B

Footer menu